Research at Kansas State University has discovered a new animal feed technology that allows for the mitigation of bacterial (such as Salmonella) and viral (such as PEDV) contamination through the use of specific blends of medium chain fatty acids and/or essential oils.
Currently, two commercially-available formaldehyde products are the only feed additives approved by the FDA for Salmonella mitigation in animal feed and/or ingredients, and there are no approved feed additives for PEDV mitigation in animal feed and/or ingredients. Formaldehyde is a potentially hazardous substance with low consumer appeal and requires users to follow both OSHA and EPA guidelines for application. In addition, formaldehyde inclusion has been hypothesized to have negative effects on protein and amino acid metabolism.
The patent pending innovation discovered at K-State overcomes these challenges. This technology provides a natural alternative to formaldehyde that would have greater consumer appeal and less employee and environmental risk. Additionally, medium chain fatty acids and essential oils have been used in animal diets to promote growth performance without any associated negative effects. While it is acknowledged that medium chain fatty acids and essential oils are currently used and approved as feed ingredients to improve animal growth and efficiency, what makes this technology novel is their use to effectively mitigate viral and bacterial pathogens in animal feed and feed ingredients.
Research at K-State showed the medium chain fatty acid blend and essential oil blend both reduced PEDV and were superior to the commercial formaldehyde products in swine diets. The blends were both effective in the mitigation of Salmonella. The medium chain fatty acid blend was superior to the formaldehyde products and all other treatments in each of the four feed matrices for Salmonella mitigation.
-Approved as feed ingredients
-Superior mitigation to formaldehyde
-Promotes growth performance
-Less employee and environmental risk
-Provisional patent application was filed in November 2014.